Entire-body PET Scans for Multiple Sclerosis

Description

To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.

Conditions

Multiple Sclerosis

Study Overview

Study Details

Study overview

To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.

Exploratory Study of Entire-body PET Scans for Multiple Sclerosis

Entire-body PET Scans for Multiple Sclerosis

Condition
Multiple Sclerosis
Intervention / Treatment

-

Contacts and Locations

Ladera Ranch

Brain Health Alliance, Ladera Ranch, California, United States, 92694

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Multiple sclerosis (MS) patients diagnosed by a credentialed neurologist experienced with care of multiple sclerosis patients.
  • * Normal healthy subjects.
  • * Willing and able to lie motionless on the PET-CT scanner bed for at least 10 minutes and up to 20 minutes for the duration of the PET-CT medical imaging scan.
  • * Any additional complicating medical illness other than MS including any other neuropsychiatric illness unrelated to MS diagnosed prior to the onset of initial symptoms of MS.
  • * Pregnancy or breast feeding.
  • * Diabetes or other metabolic-endocrine disorders.
  • * Any known concomitant acute infection.
  • * History of metastatic or locally invasive cancer.
  • * Recent surgery, chemotherapy or radiation therapy.

Ages Eligible for Study

25 Years to 55 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Brain Health Alliance,

Carl Taswell, MD, PhD, PRINCIPAL_INVESTIGATOR, Brain Health Alliance

Study Record Dates

2024-10-30